MedTrace Logo

Feasibility of Time-Restricted Eating in the Treatment of Type 2 Diabetes

NCT05375695 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-11-17

No results posted yet for this study

Summary

The overall aim of this pilot study is to examine feasibility of a 12-week 10-hour time-restricted eating intervention in individuals with overweight or obesity and type 2 diabetes. The results of the pilot study will inform recruitment, design and delivery of a future long-term time-restricted randomized controlled trial.

Conditions

Interventions

OTHER

Time-restricted eating

The intervention consists of an 8-week strict time-restricted eating period, where participants follow the same 10-hour eating window (self-selected timing from 6 am to 8 pm) each day with minimal support to obtain lived experiences with challenges associated with time-restricted eating. Followed by an individually adjusted 4-week time-restricted eating period, including supporting components. Staff will help participants select a time-interval that fits into their daily life. Diet is ad libitum and with no further dietary restrictions. The time-restricted eating intervention is an addition to standard care.

Sponsors & Collaborators

  • Hvidovre University Hospital

    collaborator OTHER

  • University of Leeds

    collaborator OTHER

  • Salk Institute for Biological Studies

    collaborator OTHER

  • University of Copenhagen

    collaborator OTHER

  • Kristine Færch

    lead OTHER

Principal Investigators

  • Kristine Færch, PhD · Steno Diabetes Center Copenhagen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2022-11-15
Completion
2022-11-15

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05375695 on ClinicalTrials.gov